Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity

• Published in: International Journal of Obesity Vol. 40; no. 1; pp. 153 - 161
• Main Authors: Dobson, R, Burgess, M I, Sprung, V S, Irwin, A, Hamer, M, Jones, J, Daousi, C, Adams, V, Kemp, G J, Shojaee-Moradie, F, Umpleby, M, Cuthbertson, D J
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01-01-2016; Nature Publishing Group
• Subjects: 59/57; 631/443/592; 692/699/2743/2037; 692/699/2743/393; Analysis; Body mass index; Cardiovascular disease; Cardiovascular diseases; Cardiovascular Diseases - etiology; Cardiovascular Diseases - physiopathology; Cardiovascular Diseases - prevention & control; Care and treatment; Chronic illnesses; Cross-Sectional Studies; Deformation; Diabetes; England - epidemiology; Epidemiology; Female; Health aspects; Health Promotion and Disease Prevention; Health risks; Humans; Hyperlipidemias - epidemiology; Hyperlipidemias - physiopathology; Insulin Resistance; Internal Medicine; Liver; Magnetic resonance imaging; Magnetic Resonance Spectroscopy; Male; Medicine; Medicine & Public Health; Metabolic Diseases; Metabolic disorders; Metabolic syndrome; Metabolic Syndrome - complications; Metabolic Syndrome - epidemiology; Metabolic Syndrome - physiopathology; Middle Aged; Mortality; Non-alcoholic Fatty Liver Disease - epidemiology; Non-alcoholic Fatty Liver Disease - physiopathology; Obesity; Obesity - complications; Obesity - epidemiology; Obesity - physiopathology; original-article; Phenotype; Prospective Studies; Public Health; Risk Factors; United Kingdom; United Kingdom > UK
• ISSN: 0307-0565; 1476-5497
• DOI: 10.1038/ijo.2015.151

Background:
The term ‘metabolically healthy obese (MHO)’ is distinguished using body mass index (BMI), yet BMI is a poor index of adiposity. Some epidemiological data suggest that MHO carries a lower risk of cardiovascular disease (CVD) or mortality than being normal weight yet metabolically unhealthy.
Objectives:
We aimed to undertake a detailed phenotyping of individuals with MHO by using imaging techniques to examine ectopic fat (visceral and liver fat deposition) and myocardial function. We hypothesised that metabolically unhealthy individuals (irrespective of BMI) would have adverse levels of ectopic fat and myocardial dysfunction compared with MHO individuals.
Subjects:
Individuals were categorised as non-obese or obese (BMI ⩾30 kg m
−2
) and as metabolically healthy or unhealthy according to the presence or absence of metabolic syndrome.
Methods:
Sixty-seven individuals (mean±s.d.: age 49±11 years) underwent measurement of (i) visceral, subcutaneous and liver fat using magnetic resonance imaging and proton magnetic resonance spectroscopy, (ii) components of metabolic syndrome, (iii) cardiorespiratory fitness and (iv) indices of systolic and diastolic function using tissue Doppler echocardiography.
Results:
Cardiorespiratory fitness was similar between all groups; abdominal and visceral fat was highest in the obese groups. Compared with age- and BMI-matched metabolically healthy counterparts, the unhealthy (lean or obese) individuals had higher liver fat and decreased early diastolic strain rate, early diastolic tissue velocity and systolic strain indicative of subclinical systolic and diastolic dysfunction. The magnitude of dysfunction correlated with the number of components of metabolic syndrome but not with BMI or with the degree of ectopic (visceral or liver) fat deposition.
Conclusions:
Myocardial dysfunction appears to be related to poor metabolic health rather than simply BMI or fat mass. These data may partly explain the epidemiological evidence on CVD risk relating to the different obesity phenotypes.